Taken together, these results indicate that high tumor-infiltrating Rab37+/PD-1+/TIM3+/CD8+ T cell level could be used as an independent factor to predict clinical outcome in patients with lung cancer. This evidence concerns the gene RAB37 and lung carcinoma.